New wrinkle injection shows promise in phase 3 trial
NCT ID NCT07427797
First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times
Summary
This study tests a single injection of IPN10200, a botulinum toxin type A, to improve moderate to severe frown lines between the eyebrows. About 300 adults will receive either the active drug or a placebo. Researchers will check how well the lines improve over 52 weeks using doctor and patient ratings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- IPN10200 (a botulinum toxin type A injection)
- What this could lead to
- If it works, this could provide a safe, effective option to temporarily reduce frown lines and improve appearance and confidence.
- What could go wrong
- This is a cosmetic treatment, not a cure. Results are temporary, and individual responses vary. Possible side effects include injection site reactions or temporary muscle weakness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE GLABELLAR LINES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Ablon Skin Institute and Research Center
RECRUITINGManhattan Beach, California, 90266, United States
-
Advanced Research Associates
RECRUITINGGlendale, Arizona, 85308, United States
-
Art of Skin MD
RECRUITINGSolana Beach, California, 92075, United States
-
Ava T. Shamban, M.D., Inc.
RECRUITINGSanta Monica, California, 90404, United States
-
Avacare
NOT_YET_RECRUITINGScottsdale, Arizona, 85260, United States
-
Bertucci MedSpa
NOT_YET_RECRUITINGWoodbridge, Ontario, L4L 8E2, Canada
-
Carruthers and Humphrey Cosmetic Medicine
RECRUITINGVancouver, British Columbia, V5Z 4E1, Canada
-
Centre de Recherche Dermatologique de Quebec
NOT_YET_RECRUITINGQuébec, Quebec, G1V4X7, Canada
-
Clinical Research Center of the Carolinas
NOT_YET_RECRUITINGCharleston, South Carolina, 29407, United States
-
Dermatology and Laser Surgery Center
RECRUITINGHouston, Texas, 77004, United States
-
ICON Dermatology and Aesthetics
RECRUITINGBethesda, Maryland, 20852, United States
-
Institute of Cosmetic and Laser Surgery
RECRUITINGOakville, Ontario, L6J 7W5, Canada
-
Investigate MD, LLC
RECRUITINGScottsdale, Arizona, 85260, United States
-
Keith A. Marcus, MD Inc
RECRUITINGRedondo Beach, California, 90277, United States
-
Pacific Clinical Innovations Inc.
RECRUITINGVista, California, 92083, United States
-
Pacific Dermaesthetics Inc.
NOT_YET_RECRUITINGVancouver, British Columbia, V6H4E1, Canada
-
Pflugerville Dermatology Clinical Research Center, Inc. d/b/a Austin Institute for Clinical Research
RECRUITINGPflugerville, Texas, 78660, United States
-
Skin Research Institute
RECRUITINGCoral Gables, Florida, 33146, United States
-
Skin Wellness Dermatology - Homewood
RECRUITINGBirmingham, Alabama, 35209, United States
-
SkinDC
RECRUITINGArlington, Virginia, 22209, United States
-
Sweat clinics of canada
RECRUITINGToronto, Ontario, M5R 3N8, Canada
-
West Dermatology
NOT_YET_RECRUITINGSan Diego, California, 92121, United States
-
Westlake Dermatology & Cosmetic Surgery - Westlake
RECRUITINGAustin, Texas, 78746-5059, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New botulinum toxin aims to smooth frown lines in phase 2 trial
- New Botox-Like injection aims to smooth frown lines safely
- New wrinkle treatment AGN-151586 tested in japanese adults
- New wrinkle treatment aims to smooth frown lines in large trial
- New wrinkle treatment eveotox takes on botox in major trial